It is possible that there are multiple alternate pathways of resistance to anti-VEGF treatment that may depend on other angiocrine factors produced by tumor endothelial cells [34] and we believe we have identified some of those factors that are relevant for proneural brain tumor model. This evidence concerns the gene VEGFA and brain neoplasm.